Connect with us

The Online Technology

Covid-19 Vaccine Front-Runners Impress Investors, but Concerns Exist – The Wall Street Journal


News & Analysis

Covid-19 Vaccine Front-Runners Impress Investors, but Concerns Exist – The Wall Street Journal

Investors are growing more convinced Covid-19 vaccines will work. They aren’t as sure shares of vaccine companies can keep soaring. The investors, along with analysts and others scrutinizing the results from early trials, say the most advanced vaccine candidates didn’t cause serious side effects and helped produce antibodies that may be sufficient…

Investors are growing more convinced Covid-19 vaccines will work.

They aren’t as sure shares of vaccine companies can keep soaring.

Real Life. Real News. Real Voices

Help us tell more of the stories that matter

Become a founding member

The investors, along with analysts and others scrutinizing the results from early trials, say the most advanced vaccine candidates didn’t cause serious side effects and helped produce antibodies that may be sufficient…

Subscribe to the newsletter news

We hate SPAM and promise to keep your email address safe

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

To Top